Scientists have engineered a virus that acts as a molecular mimic, invading cells and stealing crucial proteins from the HIV virus.
This viral thief has shown remarkable results in monkeys, effectively preventing HIV from replicating.
The success in monkeys has prompted scientists to move forward with human trials, where a small group of HIV-positive individuals will receive the engineered virus.
This innovative approach offers a promising new strategy in the fight against HIV, potentially leading to more effective treatments.
